- Published at
- by gurufocus.com
positive
positive
BioLargo Provides 2024 Review and 2025 Outlook
Continued Strong Revenue Growth; Zero Share Dilution in 2nd Half of 2024 WESTMINSTER, CA / ACCESSWIRE / January 15, 2025 / BioLargo, Inc. (OTCQX:BLGO), a compan